Who is sponsoring NCT03138824?

NCT03138824 is sponsored by Mansoura University.

What drugs are being tested in NCT03138824?

Interventions in NCT03138824: SPIES assisted TURBT, WLI assisted TURBT.

What condition does NCT03138824 study?

NCT03138824 studies Bladder Urothelial Carcinoma, TURBT, Bladder Neoplasm, Cystoscopy.

Is NCT03138824 still recruiting?

NCT03138824 is currently status unknown. Last updated 23 May 2017.

Last reviewed 2017-05-23 · How we verify

NCT03138824

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Status unknown NA Last updated 23 May 2017

What this trial tests

NA trial testing SPIES assisted TURBT in Bladder Urothelial Carcinoma in 100 participants. Status unknown.

Timeline

15 May 2017

Primary endpoint
1 May 2018

1 May 2018

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	15 May 2017
Primary completion	1 May 2018
Estimated completion	1 May 2018
Sites	1 location across Egypt

Drugs / interventions tested

SPIES assisted TURBT
WLI assisted TURBT

Conditions studied

Bladder Urothelial Carcinoma — all drugs for Bladder Urothelial Carcinoma →
TURBT — all drugs for TURBT →
Bladder Neoplasm — all drugs for Bladder Neoplasm →
Cystoscopy — all drugs for Cystoscopy →

Sponsor

Mansoura University

Who can join

18 and older, any sex, with Bladder Urothelial Carcinoma or TURBT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the therapeutic utility of SPIES assisted TURB with WLI assisted TURB in patients with non-muscle invasive bladder cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bladder Urothelial Carcinoma

Currently open trials in the same condition.

NCT06263153 — Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patie · Phase 2 · recruiting
NCT07029256 — Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB) · recruiting
NCT06416319 — Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) · NA · recruiting
NCT05296564 — Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers · Phase 1, PHASE2 · recruiting
NCT04216290 — A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) · Phase 2 · active not recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03138824 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 23 May 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03138824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing